The startup Seqera Labs, especialized in data organization and workflow software, has raised a total of 4.65 million euros in seed capital that it will use to develop its technology and increase its presence in North America.
The main investors are Talis Capital and Speedinvest, and it also has the participation of previous investors such as BoxOne Ventures and a help from the Chan Zuckerberg Initiative, founded by Mark Zuckerberg and Dr. Priscilla Chan, which supports the essential open source software in science.
The company was created in 2018 linked to the Center for Genomic Regulation, powered by the creators of Nextflow, the open source workflow and data organization software. Technology enables and simplifies deployments of data analysis in multiple cloud environments, monitors and optimizes the search for new drugs and the costs of their discovery, and accelerates clinical diagnoses and enables solutions derived from data in the field of life sciences.
The CEO and co-founder of Seqera Labs, Evan Floden, explained that this alliance offers them an “incomparable opportunity” to increase their supply and better serve customers.
“The last decade has been characterized by a growing demand for tools that can manage and process complex data. From personalized immunogenic vaccines to new diagnostics, our customers are conducting a fundamental job for our global healthThe software reached a 2020 high point during the pandemic as it was applied in global SARS-CoV-2 sequencing initiatives.
Seqera also enables advancements in the area of personalized medicine, in particular personalized oncology, a segment that is expected to grow exponentially in the coming years.